The innovative disease diagnostic platform

Click to rate this post!
[Total: 0 Your Rating: 0]

Today’s startup investment opportunity is Ionica Sciences. Ionica Sciences is employing two established technologies in the IonID platform for disease diagnosis (patent pending). IonID allows direct detection of antigens associated with difficult to diagnose diseases. The first application is Lyme disease, the fastest growing vector-borne disease in the US.

Technology: Enabling early-stage detection of Lime Disease. Will be applied to other diseases in the future.

Startup Strength Indicators:

Chief Business Officer brought his previous startup to a successful exit.

Notable Investors
The Global Lyme Alliance

Patents (pending)

Accepting investments from $1000.


Join Our Newsletter



By Registering, you agree that you've read and accepted our disclaimer, you're at least 18 years old, you consent to the terms presented on the disclaimer, and to receive notifications from us.